Global Oncology Academy

Screening Modalities for Colon Cancer: What You Need to Know
Screening Modalities for Colon Cancer: What You Need to Know
Global Oncology Academy
Screening Modalities for Colon Cancer: What You Need to Know
- Peter Buch, MD, FACG, AGAF, FACP
- Aasma Shaukat, MD, MPH
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Clinician's Roundtable
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
- Brian P. McDonough, MD, FAAFP
- Guy Young, MD
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Project Oncology®
Unresectable Hepatocellular Carcinoma Care: Investigating a Combination Therapy
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Project Oncology®
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Project Oncology®
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
- Shaji K. Kumar, MD
MinuteCE®
Understanding the Expanding Role of Antibody-Drug Conjugates in Bladder Cancer
0.50 credits 3 episodes
- Elizabeth R. Plimack, MD, MS, FASCO
- Lillibeth Velasco, MSN, RN
0.50 credits 3 episodes
Patient Perspectives on Bladder Cancer
Patient Perspectives on Bladder Cancer
MinuteCE®
Patient Perspectives on Bladder Cancer
0.50 program credits
- Elizabeth R. Plimack, MD, MS, FASCO
- Lillibeth Velasco, MSN, RN
0.50 program credits
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
MinuteCE®
Exploring New and Emerging Treatments in Muscle Invasive Bladder Cancer
0.50 program credits
- Elizabeth R. Plimack, MD, MS, FASCO
0.50 program credits

Medical News

Medical News
Open-World Video Games Found to Boost Mental Well-Being in Postgraduate Students
medicalxpress.com
01/08/2025
Read more
Medical News
Innovative Haptic Belt Shows Promise for Improving Mobility in People With Vision Loss
sciencedaily.com
01/08/2025
Read more
Medical News
New Technology Reverts Colon Cancer Cells to Normal-Like State Without Traditional Side Effects
news-medical.net
01/08/2025
Read more
Medical News
Smartphone App Reduces Opioid Use and Enhances Treatment Retention, Study Finds
news.uthscsa.edu
01/07/2025
Read more

See more news

CME/CE

Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
CME/CE
Antibody-Drug Conjugates in Bladder Cancer: Guideline Updates and Adverse Event Management
0.50 credits
- Elizabeth R. Plimack, MD, MS, FASCO
- Shilpa Gupta, MD
0.50 credits
Collaborative Insights to Solve the Puzzle of Bladder Cancer
Collaborative Insights to Solve the Puzzle of Bladder Cancer
CME/CE
Collaborative Insights to Solve the Puzzle of Bladder Cancer
1.00 credit
- Daniel P. Petrylak, MD
- Elizabeth R. Plimack, MD, MS, FASCO
- Evan Y. Yu, MD
1.00 credit
Diagnosis and Management of Metastatic PDAC
Diagnosis and Management of Metastatic PDAC
MinuteCE®
Diagnosis and Management of Metastatic PDAC
0.25 program credits
- Efrat Dotan, MD
- Shubham Pant, MD, MBBS
0.25 program credits
MinuteCE®
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC): From Diagnosis to Treatment
0.25 credits 2 episodes
- Efrat Dotan, MD
- Shubham Pant, MD, MBBS
0.25 credits 2 episodes

Clinical Practice

AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
Project Oncology®
AML Care: Examining the Efficacy and Safety of a Triplet Combination Therapy
- Charles Turck, PharmD, BCPS, BCCCP
- Anthony Stein, MD
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
Project Oncology®
The Impact of a Plant-Based Diet on Multiple Myeloma Prevention and Progression
- Urvi A. Shah, MD, MS
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Project Oncology®
Establishing D-VRd Efficacy for Transplant-Ineligible Multiple Myeloma
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Project Oncology®
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
- Charles Turck, PharmD, BCPS, BCCCP
- Prithviraj Bose, MD

Programs

An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Project Oncology®
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Reviewing the Latest Bladder Cancer Practice Guidelines
Reviewing the Latest Bladder Cancer Practice Guidelines
MinuteCE®
Reviewing the Latest Bladder Cancer Practice Guidelines
0.50 program credits
- Elizabeth R. Plimack, MD, MS, FASCO
0.50 program credits
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
CME/CE
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
0.50 credits
- Javier Cortes, MD, PhD
- Hope S. Rugo, MD, FASCO
0.50 credits
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
Project Oncology®
A Patient-Centered Approach to Managing Anemia in Myelofibrosis
- Brian P. McDonough, MD, FAAFP
- John Mascarenhas, MD
- Lucia Masarova, MD